You have 7 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

adult-type diffuse gliomas

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Recurrent IDH1/2 Mutated Glioma Trial in Paris (Azacitidine)

Recruiting
  • Recurrent IDH1/2 Mutated Glioma
  • Paris, France
    Pitie Salpetriere Hospital
Aug 29, 2022

Pediatric Recurrent/Refractory BRAFV600E-mutant Gliomas Trial in Canada, United States (Vemurafenib)

Active, not recruiting
  • Pediatric Recurrent/Refractory BRAFV600E-mutant Gliomas
  • Los Angeles, California
  • +20 more
Jan 4, 2023

Glioblastoma, Glioblastoma Multiforme, Glioblastoma Multiforme of Brain Trial in Hershey (Ketoconazole)

Recruiting
  • Glioblastoma
  • +3 more
  • Hershey, Pennsylvania
    Penn State Milton S Hershey Medical Center
Jul 12, 2022

fMRI Study of Functional Reorganization in Glioma Patients

Not yet recruiting
  • Glioma
  • GE 3.0T MRI
  • (no location specified)
Aug 19, 2021

Brain and CNS Tumors Trial in Memphis (GDC-0084, radiation therapy)

Completed
  • Brain and Central Nervous System Tumors
  • Memphis, Tennessee
    St. Jude Children's Research Hospital
Jan 13, 2023

Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma Trial in

Completed
Has Results
  • Adult Nasal Type Extranodal NK/T-cell Lymphoma
  • +35 more
  • Akt inhibitor MK2206
  • laboratory biomarker analysis
  • Houston, Texas
    M D Anderson Cancer Center
Oct 14, 2020

Glioma, Glioma Intracranial, Gliomas Benign Trial (RNS System Implantation)

Not yet recruiting
  • Glioma
  • +5 more
  • RNS System Implantation
  • (no location specified)
Nov 10, 2021

Diffuse Midline Glioma (DMG), Glioblastoma, Recurrent Ependymoma Trial in San Francisco, Ann Arbor, Zürich (ONC206, Standard of

Recruiting
  • Diffuse Midline Glioma (DMG)
  • +7 more
  • ONC206
  • Standard of Care Radiation Therapy
  • San Francisco, California
  • +2 more
Sep 13, 2022

Glioma Trial in United States (ONC201)

No longer available
  • Glioma
  • San Francisco, California
  • +9 more
May 19, 2022

Systemic Sclerosis, Scleroderma Trial in Worldwide (Anifrolumab (blinded), Placebo (blinded), Anifrolumab (unblinded, open

Not yet recruiting
  • Systemic Sclerosis
  • Scleroderma
  • Anifrolumab (blinded)
  • +2 more
  • Birmingham, Alabama
  • +130 more
Jun 22, 2023

Glioma, High Grade Glioma, Pontine Tumors Trial in Ann Arbor (Dasatinib, Everolimus)

Terminated
Has Results
  • Glioma
  • +2 more
  • Ann Arbor, Michigan
    University of Michigan Cancer Center
Sep 26, 2022

Glioma, Malignant, Computer-Assisted Trial in Shanghai (Validation of IDH1 mutations from the radiomics model)

Active, not recruiting
  • Glioma, Malignant
  • Computer-Assisted
  • Validation of IDH1 mutations from the radiomics model
  • Shanghai, Shanghai, China
    Huashan Hospital, Fudan University
Jul 23, 2023

Gliomas Using Radiomic Analysis

Not yet recruiting
  • Glioma
  • Radiomic analysis of imaging - MRI, PET, CT
  • (no location specified)
Sep 6, 2023

Glioma Trial in Leiden, Rotterdam (device, combination product, other)

Recruiting
  • Glioma
  • Philips Achieva 7T MRI
  • +3 more
  • Leiden, Netherlands
  • +1 more
Aug 16, 2022

Astrocytoma, IDH-Mutant, Grade 2, Astrocytoma, IDH-Mutant, Grade 3 Trial in United States (other, radiation, drug)

Active, not recruiting
  • Astrocytoma, IDH-Mutant, Grade 2
  • Astrocytoma, IDH-Mutant, Grade 3
  • Questionnaire Administration
  • +3 more
  • Phoenix, Arizona
  • +24 more
Dec 7, 2022

CNS Tumor, Diffuse Intrinsic Pontine Glioma, Diffuse Midline Glioma Trial in Seattle (SCRI-CARB7H3(s); B7H3-specific chimeric

Recruiting
  • Central Nervous System Tumor
  • +10 more
  • SCRI-CARB7H3(s); B7H3-specific chimeric antigen receptor (CAR) T cel
  • Seattle, Washington
    Seattle Children's Hospital
Dec 14, 2022

Glioblastoma Multiforme Trial in Brno (11C-Methionine PET/CT)

Recruiting
  • Glioblastoma Multiforme
  • 11C-Methionine PET/CT
  • Brno, Czech Republic, Czechia
    Masaryk Memorial Cancer Institute
Nov 3, 2022

Brain Tumor Trial in Toronto (Exablate, Doxorubicin)

Recruiting
  • Brain Tumor
  • Toronto, Ontario, Canada
    Sunnybrook Research Institute
Jan 5, 2023

Glioma of Spinal Cord, Glioma of Brainstem Trial in Stanford (GD2 CAR T cells, Fludarabine, Cyclophosphamide)

Recruiting
  • Glioma of Spinal Cord
  • Glioma of Brainstem
  • GD2 CAR T cells
  • +2 more
  • Stanford, California
    Lucile Packard Children's Hospital (LPCH)
Jun 22, 2022

Space Occupying Lesions of the Brain

Recruiting
  • Brain Tumor
  • +2 more
  • MR-scans using a 3T Prisma and a 7T Terra scanner (Siemens, Erlangen Germany)
  • Bern, Switzerland
    Institute for Diagnostic and Interventional Neuroradiology, Univ
Jan 26, 2023

High-grade Glioma, Solid Tumor, Unspecified, Child Trial in Edison (2-OHOA)

Recruiting
  • High-grade Glioma
  • Solid Tumor, Unspecified, Child
  • Edison, New Jersey
    Hackensack Meridian Health, Inc
Aug 16, 2022

Diffuse Intrinsic Pontine Glioma, Diffuse Midline Glioma, H3 K27M-Mutant Trial in New York (Etoposide; Oral, 50 Mg, Focused

Recruiting
  • Diffuse Intrinsic Pontine Glioma
  • Diffuse Midline Glioma, H3 K27M-Mutant
  • Etoposide; Oral, 50 Mg
  • Focused ultrasound with neuro-navigator-controlled sonication
  • New York, New York
    Columbia University Irving Medical Center
Feb 28, 2023

Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma Trial in

Completed
Has Results
  • Adult Nasal Type Extranodal NK/T-cell Lymphoma
  • +18 more
  • Scottsdale, Arizona
  • +1 more
Sep 28, 2020

2D Non-Navigated Intraoperative Ultrasound in Glioma Surgery

Recruiting
  • Glioma
  • +4 more
  • intraoperative ultrasound
  • Valladolid, Spain
    University Hospital Rio Hortega
May 16, 2023

Low Grade Glioma of Brain Trial in Durham (PEPIDH1M vaccine + vorasidenib)

Not yet recruiting
  • Low Grade Glioma of Brain
  • PEPIDH1M vaccine + vorasidenib
  • Durham, North Carolina
    Duke University Medical Center
Nov 2, 2022